Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Goodman

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Kidney International|July 1, 1987
"High-dose" calcitriol for control of renal osteodystrophy in children on CAPDI B Salusky, R N Fine, H Kangarloo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overloadP C D'Haese, M M Couttenye, W G Goodman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1990
Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patientsI B Salusky, W G Goodman, R Horst, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1987
Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysisG M Shah, R L Winer, R E Cutler, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
A nuclear juvenile hormone-binding protein from larvae of Manduca sexta: a putative receptor for the metamorphic action of juvenile hormoneS R Palli, K Touhara, J P Charles, et al.
The New England Journal of Medicine|May 18, 2000
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysisW G Goodman, J Goldin, B D Kuizon, et al.
Bone|November 1, 1995
Histomorphometric and biochemical characterization of bone following acute severe burns in childrenG L Klein, D N Herndon, W G Goodman, et al.
Clinical Nephrology|April 10, 2008
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidismH H Malluche, M-C Monier-Faugere, G Wang, et al.
Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Kidney International|July 1, 1987
"High-dose" calcitriol for control of renal osteodystrophy in children on CAPDI B Salusky, R N Fine, H Kangarloo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 1995
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overloadP C D'Haese, M M Couttenye, W G Goodman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1990
Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patientsI B Salusky, W G Goodman, R Horst, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1987
Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysisG M Shah, R L Winer, R E Cutler, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
A nuclear juvenile hormone-binding protein from larvae of Manduca sexta: a putative receptor for the metamorphic action of juvenile hormoneS R Palli, K Touhara, J P Charles, et al.
The New England Journal of Medicine|May 18, 2000
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysisW G Goodman, J Goldin, B D Kuizon, et al.
Bone|November 1, 1995
Histomorphometric and biochemical characterization of bone following acute severe burns in childrenG L Klein, D N Herndon, W G Goodman, et al.
Clinical Nephrology|April 10, 2008
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidismH H Malluche, M-C Monier-Faugere, G Wang, et al.
Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
Pageof 12